| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910637709603321 |
|
|
Titolo |
Cardiovascular Complications of COVID-19 : Acute and Long-Term Impacts / / edited by Maciej Banach |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2022 |
|
|
|
|
|
|
|
|
|
ISBN |
|
9783031154782 |
9783031154775 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed. 2022.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (434 pages) |
|
|
|
|
|
|
Collana |
|
Contemporary Cardiology, , 2196-8977 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Cardiology |
Malalties cardiovasculars |
COVID-19 |
Llibres electrònics |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
Nota di contenuto |
|
Part I: Introduction -- Biology of SARS-CoV-2 coronavirus; origin, structure, and variants -- Epidemiology of COVID-19 -- Clinical symptoms and course of COVID-19 -- Risk factors of developing COVID-19 and its severe course -- Prognosis in COVID-19 patients - statistics, risk factors -- Part II: Cardiovascular Implications of the Acute Phase of COVID-19 -- Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Acute coronary syndrome – destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogen-esis and treatment) -- Acute Vascular Injury in COVID-19 -- Heart failure and acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Arrhythmias in COVID-19 -- Thromboembolic events in COVID-19 -- Stroke in COVID-19 -- Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Interaction of anti-COVID-19 drugs with cardiovascular therapy -- Part |
|
|
|
|
|
|
|
|
|
|
|
III: Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19 -- Beyond the vaccines-Bioactive lipids in COVID-19 -- Statins and COVID-19 (mechanism of action, effect on prognosis) -- Covid-19 And Antihypertensive Treatment -- Colchicine in COVID-19 (mechanism of action, effect on prognosis) -- Antiplatelet drugs in COVID-19: mechanism of action and effect on prognosis -- Antidiabetic drugs in COVID-19 -- Part IV: Cardiovascular Complications of Long-COVID-19 -- Long COVID-19 - Definition, Epidemiology, and Clinical Implications -- Cardiovascular complications of long COVID-19 - prevalence, diagnosis and risk factors -- Cardiovascular complications of Long-COVID – management -- Part V The impact of COVID-19 pandemic on the e-services and digital tools development in medicine -- The impact of the COVID-19 pandemic on e-services and digital tools development in medicine. |
|
|
|
|
|
|
Sommario/riassunto |
|
This book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19. Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors. Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs. |
|
|
|
|
|
|
|
| |